CoChat

Understanding US addiction physicians' low rate of naltrexone prescription

Mark, T · 2003 · Drug and Alcohol Dependence

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Abstract

Naltrexone was approved by the US Food and Drug Administration (FDA) in December 1994. Although it is one of only two medications for alcohol rehabilitation approved in the US, naltrexone is not frequently prescribed. This paper examines the factors limiting physicians' use of naltrexone. Data were collected through a survey of US physician members of two addiction medicine professional associations. Logistic regression analysis was conducted with the dependent variable being any prescription of naltrexone. Independent variables consisted of physician practice characteristics, physician ratings of naltrexone's attributes (e.g. efficacy), physicians' patient characteristics, and physicians' exposure to information about naltrexone. On average, addiction medicine physicians prescribed naltrexone to 13% of their alcoholism patients. The two main self-reported reasons why physicians did not prescribe the medication to more patients were that patients refused to take the medication or comply with prescribing regimes (23%), and that patients could not afford the medication (21%). Multivariate results indicated that physician perceptions of naltrexone's effectiveness and safety were significantly associated with prescribing. Physicians who had more exposure to information about the product (e.g. by reading more journal articles about naltrexone) were more likely to prescribe it. In summary, multiple factors are contributing to the relatively low naltexone prescription rate.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0376-8716(03)00134-0

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Cited by

See all 122

Metadata

Authors
Mark, T.
Corresponding author
Mark, T
ORCID
Mark, T
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2003-09-10
Volume
71
Issue
3
Pages
219-228
ISSN
0376-8716 (ISSN-L)
OpenAlex
W2161761640
Cited by
120
References
41
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 5 · 2014: 5 · 2013: 5 · 2012: 5
FWCI
3.14
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Drug and Alcohol Dependence (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01aa012146-02)
  • National Institute on Alcohol Abuse and Alcoholism (K24 AA13736, R01-AA12146-01A1, K24AA013736)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
naltrexone, prescription rates, alcoholism treatment, medication adherence, patient refusal, drug affordability, barriers to prescribing
MeSH terms
Data Collection, Humans, Naltrexone, Patient Compliance, Physicians, Drug Prescriptions, United States, Multivariate Analysis, Logistic Models, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Understanding US addiction physicians' low rate of naltrexone prescription. https://app.cochat.ai/papers/10.1016/s0376-8716(03)00134-0
The paper
Mark, T. (2003). Understanding US addiction physicians' low rate of naltrexone prescription. Drug and Alcohol Dependence. https://doi.org/10.1016/s0376-8716(03)00134-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.